Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort

Autores

DOI:

https://doi.org/10.11606/s1518-8787.2024058005585

Palavras-chave:

Contraceptive Agents, Contraindications, Progesterone, Contraceptives, Oral, Combined, Intrauterine Devices

Resumo

OBJECTIVE: To describe the prevalence of contraindicated use of combined hormonal contraceptives, progesterone-only contraceptives, and intrauterine devices in mothers participating in the 2015 Pelotas Birth Cohort according to the WHO medical eligibility criteria. METHODS: The biological mothers of children belonging to the 2015 Pelotas birth cohort who attended the 48-month follow-up were studied. The 48-month follow-up data were collected from January 1, 2019, to December 31, 2019. Contraindicated use of modern contraceptives was considered to occur when these women presented at least one of the contraindications for the use of modern contraceptives and were using these methods. The prevalence of contraindicated use was calculated according to each independent variable and their respective 95% confidence intervals (95%CI). RESULTS: The analyzed sample consisted of 3,053 women who used any modern contraceptive method. The prevalence of contraindicated use of modern contraceptives totaled 25.9% (95%CI: 24.4–27.5). Combined hormonal contraceptives showed the highest prevalence of contraindicated use (52.1%; 95%CI: 49.3–54.8). The prevalence of contraindicated use of modern contraceptives methods was greater in women with family income between one and three minimum wages, a 25–30 kg/m2 body mass index, indication by a gynecologist for the used method, and purchasing the contraceptive method at a pharmacy. The higher the women’s education, the lower the prevalence of inappropriate use of modern contraceptives. CONCLUSION: In total, one in four women used modern contraceptives despite showing at least one contraindication. Policies regarding women’s reproductive health should be strengthened.

Referências

Festin MP, Kiarie J, Solo J, Spieler J, Malarcher S, Van Look PF, et al. Moving towards the goals of FP2020: classifying contraceptives. Contraception. 2016 Oct;94(4):289-94. https://doi.org/10.1016/j.contraception.2016.05.015

Hubacher D, Trussell J. A definition of modern contraceptive methods. Contraception. 2015 Nov;92(5):420-1. https://doi.org/10.1016/j.contraception.2015.08.008

Chibuye N. Family structure and modern contraceptive use among women in Malawi. Johannesburg: University of the Witwatersrand; 2016.

Daniels K, Daugherty J, Jones J, Mosher W. Current contraceptive use and variation by selected characteristics among women aged 15-44: United States, 2011-2013. Natl Health Stat Rep. 2015 Nov;86(86):1-14.

Cleland J, Conde-Agudelo A, Peterson H, Ross J, Tsui A. Contraception and health. Lancet. 2012 Jul;380(9837):149-56. https://doi.org/10.1016/S0140-6736(12)60609-6

Silverstein RG, Fitz V, Thornton M, Carter A, Morse JE. Contraceptive use and counseling in patients with systemic lupus erythematosus. Contraception. 2022 Jan;105:46-50. https://doi.org/10.1016/j.contraception.2021.08.017

World Health Organization. Medical eligibility criteria for contraceptive use. 5th ed. Geneva: World Health Organization; 2015.

Rodriguez MI, Kaufman M, Manibusan B, Anderson L, McConnell KJ. Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist. Contraception. 2021 Nov;104(5):547-52.

https://doi.org/10.1016/j.contraception.2021.06.004

Assiri GA, Bannan DF, Alshehri GH, Alshyhani M, Almatri W, Mahmoud MA. The contraindications to combined oral contraceptives among reproductive-aged women in an obstetrics and gynaecology clinic: a single-centre cross-sectional study. Int J Environ Res Public Health. 2022 Jan;19(3):1567. https://doi.org/10.3390/ijerph19031567

Erly SJ, Forward TR, Rogers ZH, Hawes SE, Micks E. Contraceptive use among women in the United States aged 18-44 Years with selected medical contraindications to estrogen. J Womens Health (Larchmt). 2022 Apr;31(4):580-5. https://doi.org/10.1089/jwh.2020.8905

Corrêa DA, Felisbino-Mendes MS, Mendes MS, Malta DC, Velasquez-Melendez G. Factors associated with the contraindicated use of oral contraceptives in Brazil. Rev Saude Publica. 2017 Jan;51(0):1-10. https://doi.org/10.1590/s1518-8787.2017051006113

Judge CP, Zhao X, Sileanu FE, Mor MK, Borrero S. Medical contraindications to estrogen and contraceptive use among women veterans. Am J Obstet Gynecol. 2018(2);218:234.e1-.e9. https://doi.org/10.1016/j.ajog.2017.10.020

Lauring JR, Lehman EB, Deimling TA, Legro RS, Chuang CH. Combined hormonal contraception use in reproductive age women with contraindications to estrogen use. Am J Obstet Gynecol. 2016;215(3):330.e-.e7. https://doi.org/10.1016/j.ajog.2016.03.047

Ministério da Saúde (BR). Guia prático do Programa Saúde da Família. 4th edition. Brasília, DF: Ministério da Saúde; 2001.

Ministério da Saúde (BR). Secretaria de Política de Saúde. Área Técnica de Saúde da Mulher. Assistência em planejamento familiar: manual técnico. Brasília, DF: Ministério da Saúde; 2002. (SérieA. Normas e Manuais Técnicos, n. 40).

Moura ER, Silva RM, Galvão MT. Dinâmica do atendimento em planejamento familiar no Programa Saúde da Família no Brasil. Cad Saude Publica. 2007 Apr;23(4):961-70. https://doi.org/10.1590/S0102-311X2007000400023

Instituto Brasileiro de Geografia e Estatística. Estimativa populacional de 2020: Pelotas. 2020 [cited 2020 Aug 30]. Available from: https://cidades.ibge.gov.br/brasil/rs/pelotas/panorama

Hallal PC, Bertoldi AD, Domingues MR, Silveira MF, Demarco FF, Silva IC, et al. Cohort Profile: The 2015 Pelotas (Brazil) Birth Cohort Study. Int J Epidemiol. 2018 Aug;47(4):1048-1048h. https://doi.org/10.1093/ije/dyx219

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. https://doi.org/10.1016/j.jbi.2008.08.010

Daniels K, Mosher WD, Jones J. Contraceptive methods women have ever used: United States, 1982-2010. Natl Health Stat Rep. 2013 Feb;(62):1-15.

Rodríguez-Rodríguez R, Polentinos-Castro E, Azcoaga-Lorenzo A, González-Fernández C. Uso de la anticoncepción con solo gestágenos en atención primaria: estudio GESTAGAP. Aten Primaria. 2019 Oct;51(8):479-85. https://doi.org/10.1016/j.aprim.2018.05.005

Trindade RE, Siqueira BB, Paula TF, Felisbino-Mendes MS. Contraception use and family planning inequalities among Brazilian women. Cien Saude Colet. 2021 Aug;26 suppl 2:3493-504. https://doi.org/10.1590/1413-81232021269.2.24332019

Hugon-Rodin J, Horellou MH, Conard J, Gompel A, Plu-Bureau G. Combined hormonal contraceptives and first venous thrombosis in young French women: impact of thrombotic family history. J Endocr Soc. 2017 Apr;1(6):762-71. https://doi.org/10.1210/js.2017-00090

Costa JSD, D’Elia PB, Moreira MR. Prevalência de uso de métodos contraceptivos e adequação do uso de anticoncepcionais orais na cidade de Pelotas, Rio Grande do Sul, Brasil. Cad Saude Publica. 1996;12(3):339-44. https://doi.org/10.1590/S0102-311X1996000300007

Dias-Da-Costa JS, Gigante DP, Menezes AM, Olinto MT, Macedo S, Britto MA, et al. Uso de métodos anticoncepcionais e adequação de contraceptivos hormonais orais na cidade de Pelotas, Rio Grande do Sul, Brasil: 1992 e 1999. Cad Saude Publica. 2002;18(1):93-9. https://doi.org/10.1590/S0102-311X2002000100010

Doshi JS, French RS, Evans HE, Wilkinson CL. Feasibility of a self-completed history questionnaire in women requesting repeat combined hormonal contraception. J Fam Plann Reprod Health Care. 2008 Jan;34(1):51-4. https://doi.org/10.1783/147118908783332203

Grossman D, White K, Hopkins K, Amastae J, Shedlin M, Potter JE. Contraindications to combined oral contraceptives among over-the-counter compared with prescription users. Obstet Gynecol. 2011 Mar;117(3):558-65. https://doi.org/10.1097/AOG.0b013e31820b0244

Poobalan A, Aucott L. Obesity among young adults in developing countries: a systematic overview. Curr Obes Rep. 2016 Mar;5(1):2-13. https://doi.org/10.1007/s13679-016-0187-x

Machado RB, Ushikusa TE, Monteiro IM, Guazzelli CA, Bella ZJ, Politano CA, et al. Different perceptions among women and their physicians regarding contraceptive counseling: results from the TANCO Survey in Brazil. Rev Bras Ginecol Obstet. 2020 May;42(5):255-65. https://doi.org/10.1055/s-0040-1712145

Schwarz EB, Postlethwaite D, Hung YY, Lantzman E, Armstrong MA, Horberg MA. Provision of contraceptive services to women with diabetes mellitus. J Gen Intern Med. 2012 Feb;27(2):196-201. https://doi.org/10.1007/s11606-011-1875-6

Pompei LM, Fernandes CE, Steiner ML, Strufaldi R, Melo NR. Attitudes, knowledge and prescribing habits of Brazilian gynecologists regarding extended-cycle oral contraceptives. Gynecol Endocrinol. 2013 Dec;29(12):1071-4. https://doi.org/10.3109/09513590.2013.831833

Publicado

2024-02-21

Edição

Seção

Artigos Originais

Como Citar

Houvèssou, G. M., Farías-Antúnez, S., Bertoldi, A. D., & Silveira, M. F. da. (2024). Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort. Revista De Saúde Pública, 58(1), 2. https://doi.org/10.11606/s1518-8787.2024058005585

Dados de financiamento